Tag: Psilocin

US-listed BioAdaptives, Inc. (OTCID: BDPT) has signed a definitive agreement to acquire Xycota Biosciences LLC, a privately held biotechnology company ...

Early clinical data presented at the ECNP Congress show predictable psychedelic effects and measurable changes in brain activity, as the ...

Entropy Neurodynamics, GH Research and Helus Pharma are taking different approaches to a shared challenge: developing psychedelic medicines that can ...

Melbourne-based Entropy Neurodynamics is advancing an intravenous psilocin programme spanning binge eating disorder, depression and other neuropsychiatric conditions, with recent ...

Entropy Neurodynamics has reported sustained improvements in treatment-resistant binge-eating disorder three months after patients received two infusions of its IV ...

Australian psychedelic biotechnology company Entropy Neurodynamics (ASX: ENP) has secured Human Research Ethics Committee (HREC) approval to begin what it ...

Australian biotechnology company Entropy Neurodynamics (ASX: ENP) has reported encouraging topline results from the first cohort of its Phase 2 ...